ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life"

  • Abstract Number: PP13 • ACR Convergence 2024

    Bridging the Gap from Pediatric to Adult Rheumatology Care

    Natasha Trehan, University of Ottawa, Take a Pain Check Foundation, Markham, ON, Canada

    Background/Purpose: When I was 13, life took an unexpected turn with a diagnosis of Juvenile Idiopathic Arthritis (JIA). Overnight, my world transformed into a cycle…
  • Abstract Number: 0616 • ACR Convergence 2024

    Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus

    Victoria Delk1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, North Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with the potential to severely diminish patients' quality of life (QoL). SLE disproportionately affects young…
  • Abstract Number: 1253 • ACR Convergence 2024

    Patterns of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus with or Without Concurrent Fibromyalgia

    Heather Gold1, Yi Li1, Rebecca Anthopolos1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Brooke Cohen1, Kamil Barbour4, Amit Saxena5, H Michael Belmont5, Chung-E Tseng6 and Kelly Corbitt7, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Medical Center- Division of Rheumatology, New York, NY, 4CDC, Alpharetta, GA, 5NYU School of Medicine, New York, NY, 6NYU Langone Health, Flushing, NY, 7University of Miami Miller School of Medicine, El Portal, FL

    Background/Purpose: Patients with SLE often have concomitant FM or symptoms similar to FM, including chronic pain, fatigue, sleep disturbance, and/or depression, potentially distinct from immune-mediated…
  • Abstract Number: 2150 • ACR Convergence 2024

    Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective

    Pallavi Arun1, Nikita Parashar1, Sakshi Sharma1, Kanika Arora1, Vandana Padmanabhan1 and Alvaro Arjona2, 1Novartis Healthcare Private Limited, Hyderabad, Telangana, India, 2Novartis Farmaceutica, S.A., Madrid, Madrid, Spain

    Background/Purpose: Analyzing social media conversations of patients (pts) and caregivers can be useful to understand the real-world perspectives thereby improving quality of healthcare.1 GCA and…
  • Abstract Number: PP16 • ACR Convergence 2024

    Utilization of My Knee Notes for Enhanced Healthcare Management

    Tien Sydnor-Campbell, Medically Retired, Philadelphia, PA

    Background/Purpose: Living with chronic knee issues for 40 years has been incredibly challenging. My knee pain began as early as 6th grade but got overlooked…
  • Abstract Number: 0626 • ACR Convergence 2024

    Impact of the Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) Patient Reported Outcome (PRO) in Systemic Lupus Erythematosus Patients from the Almenara Lupus Cohort

    Manuel Ugarte-Gil1, RV, Gamboa-Cardenas2, Victor Pimentel-Quiroz3, Cristina Reategui4, Claudia Elera Fitzcarrald5, Samira García-Hirsh6, José Alfaro-Lozano6, Cesar Pastor-Asurza6, Zoila Rodriguez-Bellido6, Risto Perich-Campos6 and Graciela Alarcon7, 1Universidad Cientifica del Sur, Lima, Lima, Peru, 2Universidad Científica del Sur, Lima, Lima, Peru, 3Universidad Científica del Sur/Hospital Nacional Guillermo Almenara Irigoyen, Magdalena del Mar, Peru, 4Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen, EsSalud/Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen/Universidad San Ignacio de Loyola, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Lima, Peru, 7The University of Alabama at Birmingham, Oakland, CA

    Background/Purpose: Physician-reported disease activity has a modest association with patient-reported outcomes (PROs) in systemic lupus erythematosus patients. The aim of this study is to evaluate…
  • Abstract Number: 1254 • ACR Convergence 2024

    The Impact of Eosinophilic Granulomatosis with Polyangiitis on the Health-Related Quality of Life of Patients and Their Ability to Work: Evidence from a Real-World Survey in Clinical Practice

    Robert Spiera1, Paul Dolin2, Anat Shavit2, Jennifer Rowell3, Chris Edmonds4, Josefine Persson5, Danuta Kielar6, Daniel Mascia7, James Siddall7, Tia Pennant7, Fritha Hennessy7 and Stephanie Y. Chen8, 1Scleroderma, Vasculitis, and Myositis Center, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 2BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom, 3Market Access and Pricing, AstraZeneca, Cambridge, England, United Kingdom, 4Market Access and Pricing, AstraZeneca, Gaithersburg, MD, 5Market Access and Pricing, AstraZeneca, Gothenburg, Sweden, 6Biopharmaceuticals Medicine, AstraZeneca, Cambridge, United Kingdom, 7Adelphi Real World, Bollington, United Kingdom, 8BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody-associated vasculitis that confers significant disease burden. This real-world study described the impact of…
  • Abstract Number: 2152 • ACR Convergence 2024

    Factors Associated with Health-related Quality of Life in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – a Cross Sectional Analysis from the SAPHO-CNO Study

    Aleksander Lenert1, Helena Abodeely1, Karmela Kim Chan2, Sandy Hong3, Arundathi Jayatilleke4, Courtney Kremer5, Emma Leisinger1, Petar Lenert6, Melissa Oliver7, T. Shawn Sato8, Melanie Smith2, Thomason Jenna9, Yongdong (Dan) Zhao10, Jonathan Templin1, Robyn Domsic11, Mary Vaughan-Sarrazin1, Daniel Solomon12 and Polly Ferguson13, 1University of Iowa, Iowa City, IA, 2Hospital For Special Surgery, New York, NY, 3University of Iowa Stead Family Children's Hospital, Iowa City, IA, 4Temple University, Philadelphia, PA, 5University of Iowa Stead Family Children's Hospital, Solon, Iowa, IA, 6University of Iowa Hospitals and Clinics, Iowa City, IA, 7Indiana University, Indianapolis, IN, 8University of Iowa, Iowa City, 9University of Washington, Division of Rheumatology, Seattle, WA, 10University of Washington, Redmond, WA, 11Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 12Brigham and Women's Hospital, Newton, MA, 13University of Iowa Carver College of Medicine, Iowa City, IA

    Background/Purpose: Health-related quality of life (HRQOL) is decreased in individuals with chronic rheumatic diseases (CRD) yet remains undefined in adults with SAPHO syndrome and chronic…
  • Abstract Number: 0145 • ACR Convergence 2024

    Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus

    Leila Milanfar1, Jinoos Yazdany2, Amanda Eudy3, Courtney Hoge4, Charmayne M. Dunlop-Thomas5, Patti Katz6 and Laura Plantinga7, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Duke University, Raleigh, NC, 4Emory University, Atlanta, GA, 5Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 6UCSF, San Rafael, CA, 7University of California, San Francisco, San Francisco, CA

    Background/Purpose: Measurement of the extent to which individuals move throughout their community and participate in social activities (“community mobility”) can provide a snapshot of how…
  • Abstract Number: 0635 • ACR Convergence 2024

    Medical Record Natural Language Processing and Patient Biometric and Self-Reported Measures Inform an Artificial Intelligence Augmented Remote Care Management Strategy for Lupus Patients

    Gerald Lushington1, Bruce Wang2, Mohan Purushothaman3, Melissa Munroe4, Vijay R. Nadipelli5, Bernard Rubin2, Jessica Crawley2, Beth Valashinas6, Reshma Khan7, Anil Warrier8, Joseph Huffstutter9, Jennifer Murphy10, Lizeth Santamaria2, Sneha Nair2, Georg Armstrong2, Sandeep Nair2, Daniele DeFreese3, Adrian Holloway3, Arif Sorathia2, Brett Adelman2, Fabricio Pautasso2 and Eldon Jupe3, 1Progentec Diagnostics, Inc, Oklahoma City, OK, 2Progentec Diagnostics, Inc., Oklahoma City, OK, 3Progentec Diagnostics, Inc., Oklahoma City, 4Oklahoma Medical Research Foundation; Progentec Diagnostics, Inc., Oklahoma City, OK, 5GSK, Medical Evidence Generation, Philadelphia, PA, 6Physicians Alliance of Connecticut, Milford, CT, 7Palm Beach Rheumatology and Wellness Center, Jupiter, FL, 8Millennium Rheumatology, Conroe, TX, 9Arthritis Associates PLLC, Signal Mountain, TN, 10Articularis Healthcare, Summerville, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is one of several rheumatologic disorders that presents frequent healthcare challenges, particularly for socioeconomic and geographically disadvantaged patients. Due to…
  • Abstract Number: 1319 • ACR Convergence 2024

    Impact of Illness Cognition and Self-Esteem on Quality of Life in Reproductive-Age Women with Autoimmune Rheumatic Diseases

    Ana Rodriguez-Flores1, Galilea Rodriguez2, Mara Ponce3, Anahí Carrazco Chapa4, Karen Aglae Chavez-Olivo2, Aldo Patricio Romero-Avila2, Valeria Monserrat De Hoyos-Perez5, Jesus Cardenas-de la Garza3, Lorena Perez-Barbosa6, CASSANDRA SKINNER TAYLOR7 and Dionicio Galarza-Delgado8, 1Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 3Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 6Hospital Universitario, UANL, Monterrey, Mexico, 7HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 8UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Autoimmune rheumatic diseases (ARDs) are inflammatory conditions associated with impaired joint mobility, recurrent pain, and fatigue leading to poor emotional health and negative feelings…
  • Abstract Number: 2154 • ACR Convergence 2024

    “I Have Taken Five Different Kinds of Tablets and Injections, and I Still Have Foot Pain”: An International Outcome Measures in Rheumatology (OMERACT) Qualitative Study Exploring Patient Perspectives of Foot and Ankle Disorders

    Lara Chapman1, Caroline Flurey2, Anthony C. Redmond1, Pam Richards3, Eiman Soliman4, Abdelhfeez Moshrif5, Lucy Malone6, Christopher Joyce7, Marian Hannan8, Philip S. Helliwell9, Catherine Hofstetter10, Hylton Menz11, Beverley Shea12 and Heidi Siddle1, 1University of Leeds, Leeds, United Kingdom, 2University of the West of England, Bristol, Bristol, United Kingdom, 3OMERACT, Bristol, United Kingdom, 4Alexandria Faculty of Medicine, Alexandria, Egypt, 5Al-azhar university, Assiut, Egypt, 6Harrogate and District NHS Foundation Trust, Harrogate, United Kingdom, 7Homerton Healthcare NHS Foundation Trust, London, United Kingdom, 8Marcus Institute for Aging Research, Hebrew SeniorLife, Milton, MA, 9Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom, 10OMERACT, Toronto, Canada, 11La Trobe University, Fairfield, Victoria, Australia, 12Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: The foot and ankle are frequently affected in rheumatic and musculoskeletal diseases (RMDs), yet there is a lack of high-quality evidence to determine the…
  • Abstract Number: 0169 • ACR Convergence 2024

    Impact of Sense of Control Among People Living with SLE

    Amanda Eudy1, S. Sam Lim2, Charmayne M. Dunlop-Thomas3, Jinoos Yazdany4, Patti Katz5 and Laura Plantinga6, 1Duke University, Raleigh, NC, 2Emory University, Atlanta, GA, 3Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 4University of California San Francisco, San Francisco, CA, 5UCSF, San Rafael, CA, 6University of California, San Francisco, San Francisco, CA

    Background/Purpose: SLE is a disease characterized by cycles of remitting and relapsing symptoms that can be unpredictable, stressful, and cause an individual to feel they…
  • Abstract Number: 0661 • ACR Convergence 2024

    Validity, Reliability and Responsiveness of Lupus Impact Tracker and LupusPRO: AURORA Trial

    Meenakshi Jolly1, Matt Truman2, Ronald Flauto3 and Kathryn Dao4, and AURORA, 1Rush University Medical Center, Chicago, 2Aurinia Pharmaceuticals, Victoria, BC, Canada, 3Aurinia Pharmaceuticals, Rockville, MD, 4Aurinia Pharmaceuticals, Dallas

    Background/Purpose: Voclosporin used in addition to Mycophenolate Mofetil and low dose oral steroids in patients with active Lupus Nephritis (LN) was found to be superior…
  • Abstract Number: 1339 • ACR Convergence 2024

    When Medications Fail: A Mixed Methods Study Evaluating the Experience and Health-Related Quality of Life (HRQOL) of Adults with Rheumatoid Arthritis Non-Responsive to Treatment

    Kathleen Carluzzo1, Erin Knight1, Sidney May1, Laura Bernstein2, Kristen Mueller3, Clifton Bingham4 and Karen Schifferdecker1, 1Dartmouth College, Lebanon, NH, 2Dartmouth College, Philadelphia, PA, 3Arthritis Foundation, Washington, DC, 4Johns Hopkins University, Baltimore, MD

    Background/Purpose: RA treatment involves an iterative approach to identifying effective medications for patients. While response varies, there is little in-depth understanding of patients’ perspectives of…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 30
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology